Transparent, flexible, impermeable plastic container for storage of pharmaceutical liquids
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
B29D-022/00
B29D-023/00
B32B-001/08
출원번호
UP-0472831
(2006-06-22)
등록번호
US-7807242
(2010-10-26)
우선권정보
DK-2003 01916(2003-12-22)
발명자
/ 주소
Soerensen, Anne
Sparholt, Philip Albert
Hansen, Marianne Rye
출원인 / 주소
Novo Nordisk A/S
대리인 / 주소
Began, Marc A.
인용정보
피인용 횟수 :
47인용 특허 :
16
초록▼
A container consisting of a PCTFE monolayer, the thickness of said layer being about 40-100 μm, which container is equipped with a device where the liquid can be lead out through when desired and which container is transparent, shows superior properties for storing liquid pharmaceutical compos
A container consisting of a PCTFE monolayer, the thickness of said layer being about 40-100 μm, which container is equipped with a device where the liquid can be lead out through when desired and which container is transparent, shows superior properties for storing liquid pharmaceutical compositions, especially insulin compositions containing preservatives.
대표청구항▼
What is claimed is: 1. A flexible, at least partially transparent container for storage of a liquid in a water-tight chamber, the container comprising: a liquid pharmaceutical composition comprising, an active ingredient and at least one preservative selected from the group consisting of phenol, m-
What is claimed is: 1. A flexible, at least partially transparent container for storage of a liquid in a water-tight chamber, the container comprising: a liquid pharmaceutical composition comprising, an active ingredient and at least one preservative selected from the group consisting of phenol, m-cresol, and benzyl alcohol; the container wall material (6) consisting essentially of a weldable PCTFE monolayer, forming a chamber (5) wherein when the chamber is filled with water and when it is stored at a temperature of about 5° C. for 2 years less than 10% (weight/weight) of the content of water diffuses out from the container; and when said chamber is filled with water containing about 1.8 mg/mL (19 mM) of phenol and when it is stored at a temperature of about 5° C. for 24 months, the change in the concentration of phenol in the liquid is less than about 10%. 2. A PCTFE film, wherein the film material can be used for preparing a transparent container according to claim 1. 3. The container according to claim 1, wherein the thickness of the wall material being above about 40 μm, and being below about 100 μm. 4. The container according to claim 3 wherein the container is at least partially transparent. 5. The container according to claim 4 wherein the container is wholly transparent. 6. The container according to claim 5, from which when filled with water and when stored at a temperature of about 5° C. for 2 years less than 10%. 7. The container according to claim 6, from which when filled with water containing about 1.8 mg/mL (19 mM) of phenol and when stored at a temperature of about 5° C. for 24 months, the change in the concentration of phenol is less than about 10%. 8. The container according to claim 7, from which when filled with water containing about 1.8 mg/mL (19 mM) of phenol and when stored at a temperature of about 37° C. for 12 weeks, the change in the concentration of phenol is less than about 10%. 9. The container according to claim 8, from which when filled with water containing 2.06 mg/mL (19 mM) of m-cresol and when stored at a temperature of about 5° C. for 24 months, the change in the concentration of m-cresol is less than about 10%. 10. The container according to claim 9, from which when filled with water containing 2.06 mg/mL (19 mM) of m-cresol and when stored at a temperature of about 37° C. for 12 weeks, the change in the concentration of m-cresol is less than about 10%. 11. The container according to claim 10, which is prepared from a pouch foil which when tested by test A described herein gives a maximum loss of m-cresol of about 10%. 12. The container according to claim 11, which is prepared from a pouch foil which when tested by test A described herein gives a change in the pH value which is not more than about +/−0.2. 13. The container according to claim 12, which is prepared from a pouch foil which when tested by test B described herein gives a maximum weight loss of about 2.5%. 14. The container according to claim 13, which is prepared from a pouch foil which when tested by test B described herein gives a maximum loss of m-cresol of about 10%. 15. The container according to claim 14, which is prepared from a pouch foil which when tested by test B described herein gives a change in the pH value which is not more than about +/−0.2. 16. The container according to claim 15, which is prepared from a pouch foil which when tested by test C described herein gives a maximum weight loss of 2.5%. 17. The container according to claim 16, which is prepared from a pouch foil which when tested by test C described herein gives a maximum loss of m-cresol of about 10%. 18. The container according to claim 17 which is prepared from a pouch foil which when tested by test C described herein gives a maximum loss of phenol of about 10%. 19. The container according to claim 18, which is prepared from a pouch foil which when tested by test C described herein gives a change in the pH value which is not more than about +/−0.2. 20. The container according to acclaim 19 which is prepared from a pouch foil which fulfills test D described herein for the dilution 1:50. 21. The container according to claim 20, which container is equipped with a device whereby said liquid can be expelled from said container. 22. The container according to claim 21, which container, when completely filled with liquid, can contain an amount of liquid which is at least about 0.5 ml, and not more than about 10 ml. 23. A container according to claim 22, wherein the container is filled partially or wholly with the liquid pharmaceutical composition. 24. A container according to claim 23 wherein at least 95% (volume/volume) of the inner of the container contains the liquid pharmaceutical composition. 25. The container according to claim 24, wherein the active ingredient is a peptide. 26. The container according to claim 25 wherein the peptide is insulin. 27. The container according to claim 26 wherein the content of insulin is in the range from about 10 U/ml to about 1500 U/ml. 28. A flexible, at least partially transparent container for storage of a liquid in a water-tight chamber, the container comprising: a liquid pharmaceutical composition comprising, an active ingredient and at least one preservative selected from the group consisting of phenol, m-cresol, and benzyl alcohol; the container wall material (6) consisting essentially of a weldable PCTFE monolayer, forming a chamber (5) wherein when the chamber is filled with water and when it is stored at a temperature of about 5° C. for 2 years less than 10% (weight/weight) of the content of water diffuses out from the container; and when said chamber is filled with water containing about 1.8 mg/mL (19 mM) of phenol and when it is stored at a temperature of about 37° C. for 12 weeks, the change in the concentration of phenol in the liquid is less than about 10%. 29. A flexible, at least partially transparent container for storage of a liquid in a water-tight chamber, the container comprising: a liquid pharmaceutical composition comprising, an active ingredient and at least one preservative selected from the group consisting of phenol, m-cresol, and benzyl alcohol; the container wall material (6) consisting essentially of a weldable PCTFE monolayer, forming a chamber (5) wherein when the chamber is filled with water and when it is stored at a temperature of about 5° C. for 2 years less than 10% (weight/weight) of the content of water diffuses out from the container; and when said chamber is filled with water containing 2.06 mg/mL (19 mM) of m-cresol and when stored at a temperature of about 5° C. for 24 months, the change in the concentration of m-cresol is less than about 10%. 30. A flexible, at least partially transparent container for storage of a liquid in a water-tight chamber, the container comprising: a liquid pharmaceutical composition comprising, an active ingredient and at least one preservative selected from the group consisting of phenol, m-cresol, and benzyl alcohol; the container wall material (6) consisting essentially of a weldable PCTFE monolayer, forming a chamber (5) wherein when the chamber is filled with water and when it is stored at a temperature of about 5° C. for 2 years less than 10% (weight/weight) of the content of water diffuses out from the container; and when said chamber is filled with water containing 2.06 mg/mL (19 mM) of m-cresol and when stored at a temperature of about 37° C. for 12 weeks, the change in the concentration of m-cresol is less than about 10%. 31. A flexible, at least partially transparent container for storage of a liquid in a water-tight chamber, the container comprising: a liquid pharmaceutical composition comprising, an active ingredient and at least one preservative selected from the group consisting of phenol, m-cresol, and benzyl alcohol; the container wall material (6) consisting essentially of a weldable PCTFE monolayer, forming a chamber (5) wherein the thickness of the wall material being above about 40 μm, and being below about 100 μm.
Barney Ward W. ; Gharibian Noel ; Harvey Douglas G. ; McLonis Mark R. ; Peara Christopher D. ; Sacca Giuseppe ; Sandberg Sharilyn J. ; Smith Steven L. ; Walter William V. ; Wu Nicholas Chung-Hui ; Yo, Flexible, multiple-compartment drug container and method of making and using same.
Buch-Rasmussen Thomas,DKX ; Jannasch Patric,DKX ; J.o slashed.rgensen Erling Bonne,DKX, Medicament container of polymer of linear olefin for storing a liquid medicament.
Mizuno Toshiya,JPX ; Teramoto Yoshikichi,JPX ; Tada Yasuhiro,JPX, Stretched polychlorotrifluoroethylene film, process for the production thereof and packaged product using the film.
Felts, John T.; Fisk, Thomas E.; Abrams, Robert S.; Ferguson, John; Freedman, Jonathan R.; Pangborn, Robert J.; Sagona, Peter J., Apparatus and method for transporting a vessel to and from a PECVD processing station.
Weikart, Christopher; Clark, Becky L.; Stevenson, Adam; Abrams, Robert S.; Belfance, John; Jones, Joseph A.; Fisk, Thomas E., Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like.
Felts, John T.; Fisk, Thomas E.; Abrams, Robert S.; Ferguson, John; Freedman, Jonathan R.; Pangborn, Robert J.; Sagona, Peter J., Cyclic olefin polymer vessels and vessel coating methods.
Hyde, Roderick A.; Ishikawa, Muriel Y.; Kare, Jordin T.; Wood, Jr., Lowell L., Multi-layer insulation composite material having at least one thermally-reflective layer with through openings, storage container using the same, and related methods.
Jones, Joseph A.; Felts, John T.; Gresham, James Troy; Lilly, Brian Russell; Fisk, Thomas E., PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases.
Felts, John T.; Fisk, Thomas E.; Abrams, Robert S.; Ferguson, John; Freedman, Jonathan R.; Pangborn, Robert J.; Sagona, Peter J.; Weikart, Christopher, Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus.
Niemoeller, Elisabeth; Silvestre, Louise; Boka, Gabor; Miossec, Patrick, Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin.
Niemöeller, Elisabeth; Müehlen-Bartmer, Isabel; Silvestre, Louise; Boka, Gabor; Miossec, Patrick, Pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
Hess, Sibylle; Hoelscher, Christian; Boehme, Andrees; Menut, Agnes; Pradier, Laurent; Taupin, Veronique, Pharmaceutical composition for use in the treatment of a neurodegenerative disease.
Jones, Joseph A.; Weikart, Christopher; Martin, Steven J., Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus.
Felts, John T.; Fisk, Thomas E.; Abrams, Robert S.; Ferguson, John; Freedman, Jonathan R.; Pangborn, Robert J.; Sagona, Peter; Weikart, Christopher; Israelachvili, Jacob, Saccharide protective coating for pharmaceutical package.
Felts, John T.; Fisk, Thomas E.; Abrams, Robert S.; Ferguson, John; Freedman, Jonathan R.; Pangborn, Robert J.; Sagona, Peter J., Vessel inspection apparatus and methods.
Felts, John T.; Fisk, Thomas E.; Abrams, Robert S.; Ferguson, John; Freedman, Jonathan R.; Pangborn, Robert J.; Sagona, Peter J., Vessel inspection apparatus and methods.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.